Get started
Author

Anita K. Bakrania

Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms
2016 · Bhavesh C. Variya, Anita K. Bakrania, et al. · Pharmacological Research · 318
Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling
2019 · Bhavesh C. Variya, Anita K. Bakrania, et al. · Phytomedicine · 197
Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases
2023 · Anita Bakrania, Narottam Joshi, et al. · Pharmacological Research · 99
Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice
2018 · Bhavesh C. Variya, Anita K. Bakrania, et al. · Regulatory Toxicology and Pharmacology · 94
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment
2021 · Anita Bakrania, Gang Zheng, et al. · Pharmaceutics · 70
PDF
Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer
2016 · Anita K. Bakrania, Bhavesh C. Variya, et al. · Pharmacological Research · 53
Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety
2018 · Bhavesh C. Variya, Anita K. Bakrania, et al. · Biomedicine & Pharmacotherapy · 41
Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine
2023 · Anita Bakrania, Jeffrey To, et al. · Gastro Hep Advances · 26
PDF
RNA nanomedicine in liver diseases
2023 · Anita Bakrania, Yulin Mo, et al. · Hepatology · 23
DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition
2017 · Anita K. Bakrania, Bhavesh C. Variya, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 20
Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction
2017 · Anita K. Bakrania, Bhavesh C. Variya, et al. · Frontiers in Pharmacology · 12
PDF
Combination treatment for allergic conjunctivitis – Plant derived histidine decarboxylase inhibitor and H1 antihistaminic drug
2015 · Anita K. Bakrania, Snehal S. Patel · Experimental Eye Research · 12
RETRACTED: Repeated dose 28-day oral toxicity study of DEAE-Dextran in mice: An advancement in safety chemotherapeutics
2017 · Anita K. Bakrania, Bhavesh C. Variya, et al. · Regulatory Toxicology and Pharmacology · 10
Antitumor potential of herbomineral formulation against breast cancer: Involvement of inflammation and oxidative stress
2017 · Anita K. Bakrania, Surender Nakka, et al. · 7
Ameliorative Effect of a Neoteric Regimen of Catechin plus Cetirizine on Ovalbumin-Induced Allergic Rhinitis in Rats
2022 · Mohamed A. Morsy, Snehal S. Patel, et al. · Life · 5
PDF
Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors
2020 · Anita Bakrania, Mélanie Aubé, et al. · Canadian Journal of Physiology and Pharmacology · 3
PDF
A novel auto-fluorescent porphyrin-lipid nanoparticle strategy for CTNNB1 gene silencing in hepatocellular carcinoma
2026 · Jeffrey C. To, Alyssa Apilan, et al. · Frontiers in Oncology · 2
Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases
2026 · Anita Bakrania, Anh-Thu Nguyen Lefebvre, et al. · Communications Medicine · 2
PDF
DMBA- Induced Breast Cancer: A Hormonal Camouflage
2017 · Anita K. Bakrania, Bhavesh C. Variya, et al. · Current Cancer Therapy Reviews · 2
Corrigendum to “Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety” Biomed. Pharmacother. 108 (2018) 1274–1281
2024 · Bhavesh C. Variya, Anita K. Bakrania, et al. · Biomedicine & Pharmacotherapy · 1
Pharmacological Evaluation of Jambrushila Tablet on Animal Model of Type-2 Diabetes
2015 · Bhavesh C. Variya, Anita K. Bakrania, et al. · The Natural Products Journal · 1
Corrigendum to “Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice” [Regulat. Toxicol. Pharmacol. RTP 101 (2019) 71–78]
2025 · Bhavesh C. Variya, Anita K. Bakrania, et al. · Regulatory Toxicology and Pharmacology
Corrigendum: Role of β-interferon inducer (DEAE-Dextran) in tumorigenesis by VEGF and NOTCH1 inhibition along with apoptosis induction
2024 · Anita K. Bakrania, Bhavesh C. Variya, et al. · Frontiers in Pharmacology
PDF
Corrigendum to “DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition” [Eur. J. Pharm. Biopharm. 122 (2018) 37–48]
2023 · Anita K. Bakrania, Bhavesh C. Variya, et al. · European Journal of Pharmaceutics and Biopharmaceutics
Retraction Note to: Insights from diversified anti-angiogenic models: role of β-interferon inducer DEAE-Dextran
2022 · Anita K. Bakrania, Bhavesh C. Variya, et al. · Pharmacological Reports
PDF
Works count: 28
Citation count: 998
H-index: 12
I10-index: 13
Year
Topic
Type